Carregant...
How close are we to incorporating measurable residual disease into clinical practice for acute myeloid leukemia?
Assessment of measurable residual disease, also called “minimal residual disease,” in patients with acute myeloid leukemia in morphological remission provides powerful prognostic information and complements pretreatment factors such as cytogenetics and genomic alterations. Based on data that low lev...
Guardat en:
| Publicat a: | Haematologica |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Ferrata Storti Foundation
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6669140/ https://ncbi.nlm.nih.gov/pubmed/31273094 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2018.208454 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|